The company said that it is pairing its diagnostics and life sciences businesses to support growth and focus on shared end markets and customers.

Last week, readers were most interested in a story about the development of an AI-based method to predict COPD flare-ups before symptoms appear.

According to the DOJ, Osman Syed submitted more than $79 million in fraudulent claims to Medicare and Texas Medicaid for RPP testing.

While Congress has protected labs from PAMA cuts via a series of one-year delays, this has locked lab prices at 2016 levels, ...

Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous ...

The company analyzes urine samples using a lateral flow test and optical reader combined with artificial intelligence to predict lung disease exacerbations.

The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

Scientists in California and Michigan said that their FastGlioma algorithm can improve detection of tumor infiltration at the margins of surgery sites.

NEW YORK – Startup company Amplified Sciences on Monday said it has raised $2.6 million in a Series Seed Preferred round. The round was led by Elevate Ventures and OCA Ventures with participation from ...

The agreement involves the integration of Tagomics' Interlace epigenetic profiling platform with Agilent's SureSelect library preparation and target enrichment products.

The firms said that Owkin's MSIntuit CRC v2 screening test for microsatellite instability will be available through the Proscia Concentriq software platform.